REFERENCES
1. Richards JR, Laurin EG. Methamphetamine toxicity. Statpearls .
Treasure Island (FL); 2022.
2. Freckelton I. Methamphetamine-induced psychosis and mental
impairment: A challenge from new zealand. J Law Med .
2019;27:284-293
3. Hsieh JH, Stein DJ, Howells FM. The neurobiology of methamphetamine
induced psychosis. Front Hum Neurosci . 2014;8:537
4. McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Dose-related
psychotic symptoms in chronic methamphetamine users: Evidence from a
prospective longitudinal study. JAMA Psychiatry . 2013;70:319-324
5. Homer BD, Solomon TM, Moeller RW, Mascia A, DeRaleau L, Halkitis PN.
Methamphetamine abuse and impairment of social functioning: A review of
the underlying neurophysiological causes and behavioral implications.Psychol Bull . 2008;134:301-310
6. Springer AE, Peters RJ, Shegog R, White DL, Kelder SH.
Methamphetamine use and sexual risk behaviors in u.S. High school
students: Findings from a national risk behavior survey. Prev
Sci . 2007;8:103-113
7. Lopez-Leon S, Gonzalez-Giraldo Y, Wegman-Ostrosky T, Forero DA.
Molecular genetics of substance use disorders: An umbrella review.Neurosci Biobehav Rev . 2021;124:358-369
8. Bousman CA, Glatt SJ, Everall IP, Tsuang MT. Genetic association
studies of methamphetamine use disorders: A systematic review and
synthesis. Am J Med Genet B Neuropsychiatr Genet .
2009;150B:1025-1049
9. Kotaka T, Ujike H, Okahisa Y, Takaki M, Nakata K, Kodama M, et al.
G72 gene is associated with susceptibility to methamphetamine psychosis.Prog Neuropsychopharmacol Biol Psychiatry . 2009;33:1046-1049
10. Ujike H, Kishimoto M, Okahisa Y, Kodama M, Takaki M, Inada T, et al.
Association between 5ht1b receptor gene and methamphetamine dependence.Curr Neuropharmacol . 2011;9:163-168
11. Okochi T, Kishi T, Ikeda M, Kitajima T, Kinoshita Y, Kawashima K, et
al. Genetic association analysis of nos3 and methamphetamine-induced
psychosis among japanese. Curr Neuropharmacol . 2011;9:151-154
12. Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv
Exp Med Biol . 2020;1253:3-55
13. Moore LD, Le T, Fan G. DNA methylation and its basic function.Neuropsychopharmacology . 2013;38:23-38
14. Nestler EJ, Luscher C. The molecular basis of drug addiction:
Linking epigenetic to synaptic and circuit mechanisms. Neuron .
2019;102:48-59
15. Hubel C, Marzi SJ, Breen G, Bulik CM. Epigenetics in eating
disorders: A systematic review. Mol Psychiatry . 2019;24:901-915
16. Chen D, Meng L, Pei F, Zheng Y, Leng J. A review of DNA methylation
in depression. J Clin Neurosci . 2017;43:39-46
17. Ovenden ES, McGregor NW, Emsley RA, Warnich L. DNA methylation and
antipsychotic treatment mechanisms in schizophrenia: Progress and future
directions. Prog Neuropsychopharmacol Biol Psychiatry .
2018;81:38-49
18. Fonteneau M, Filliol D, Anglard P, Befort K, Romieu P, Zwiller J.
Inhibition of DNA methyltransferases regulates cocaine
self-administration by rats: A genome-wide DNA methylation study.Genes Brain Behav . 2017;16:313-327
19. Liu C, Marioni RE, Hedman AK, Pfeiffer L, Tsai PC, Reynolds LM, et
al. A DNA methylation biomarker of alcohol consumption. Mol
Psychiatry . 2018;23:422-433
20. Fan XY, Yang JY, Dong YX, Hou Y, Liu S, Wu CF. Oxytocin inhibits
methamphetamine-associated learning and memory alterations by regulating
DNA methylation at the synaptophysin promoter. Addict Biol .
2020;25:e12697
21. Wang H, Dong X, Awan MUN, Bai J. Epigenetic mechanisms involved in
methamphetamine addiction. Front Pharmacol . 2022;13:984997
22. Stout KA, Dunn AR, Lohr KM, Alter SP, Cliburn RA, Guillot TS, et al.
Selective enhancement of dopamine release in the ventral pallidum of
methamphetamine-sensitized mice. ACS Chem Neurosci .
2016;7:1364-1373
23. Pierucci-Lagha A, Gelernter J, Chan G, Arias A, Cubells JF, Farrer
L, et al. Reliability of dsm-iv diagnostic criteria using the
semi-structured assessment for drug dependence and alcoholism (ssadda).Drug Alcohol Depend . 2007;91:85-90
24. American Psychiatric Association. Diagnostic and statistical
manual of mental disorders: Dsm-5 . Arlington, VA: American Psychiatric
Publishing; 2013.
25. Fan B, Ma J, Zhang H, Liao Y, Wang W, Zhang S, et al. Association of
fkbp5 gene variants with depression susceptibility: A comprehensive
meta-analysis. Asia Pac Psychiatry . 2021;13:e12464
26. Buss AH, Perry M. The aggression questionnaire. Journal of
personality and social psychology . 1992;63:452
27. Patton JH, Stanford MS, Barratt ES. Factor structure of the barratt
impulsiveness scale. J Clin Psychol . 1995;51:768-774
28. Zhang J, Su H, Tao J, Xie Y, Sun Y, Li L, et al. Relationship of
impulsivity and depression during early methamphetamine withdrawal in
han chinese population. Addict Behav . 2015;43:7-10
29. Chen D, Liu F, Shang Q, Song X, Miao X, Wang Z. Association between
polymorphisms of drd2 and drd4 and opioid dependence: Evidence from the
current studies. Am J Med Genet B Neuropsychiatr Genet .
2011;156B:661-670
30. Royo JL. Hardy weinberg equilibrium disturbances in case-control
studies lead to non-conclusive results. Cell J . 2021;22:572-574
31. Stark AE, Seneta E. A reality check on hardy-weinberg. Twin
Res Hum Genet . 2013;16:782-789
32. Deak JD, Johnson EC. Genetics of substance use disorders: A review.Psychol Med . 2021;51:2189-2200
33. Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward
and addiction. Physiol Rev . 2019;99:2115-2140
34. Okuyama Y, Ishiguro H, Toru M, Arinami T. A genetic polymorphism in
the promoter region of drd4 associated with expression and
schizophrenia. Biochem Biophys Res Commun . 1999;258:292-295
35. Joyce PR, Rogers GR, Miller AL, Mulder RT, Luty SE, Kennedy MA.
Polymorphisms of drd4 and drd3 and risk of avoidant and obsessive
personality traits and disorders. Psychiatry Res . 2003;119:1-10
36. Gilman TL, Ford MT, Jasnow AM, Coifman KG. Drd4 polymorphism
associated with greater positive affect in response to negative and
neutral social stimuli. Ann Hum Genet . 2022;86:218-223
37. Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, Antal P, Szilagyi
A, et al. Multivariate analysis of dopaminergic gene variants as risk
factors of heroin dependence. PLoS One . 2013;8:e66592
38. Perez-Rubio G, Ramirez-Venegas A, Noe Diaz V, Garcia Gomez L, Elvira
Fabian K, Garcia Carmona S, et al. Polymorphisms in htr2a and drd4
predispose to smoking and smoking quantity. PLoS One .
2017;12:e0170019
39. Abrahams S, McFie S, Lacerda M, Patricios J, Suter J, September AV,
et al. Unravelling the interaction between the drd2 and drd4 genes,
personality traits and concussion risk. BMJ Open Sport Exerc Med .
2019;5:e000465
40. Li Y, Baker-Ericzen M, Ji N, Chang W, Guan L, Qian Q, et al. Do snps
of drd4 gene predict adult persistence of adhd in a chinese sample?Psychiatry Res . 2013;205:143-150
41. Mitaki S, Isomura M, Maniwa K, Yamasaki M, Nagai A, Nabika T, et al.
Impact of five snps in dopamine-related genes on executive function.Acta Neurol Scand . 2013;127:70-76
42. Cadet JL, Jayanthi S. Epigenetics of addiction. Neurochem
Int . 2021;147:105069
43. Lax E, Szyf M. The role of DNA methylation in drug addiction:
Implications for diagnostic and therapeutics. Prog Mol Biol Transl
Sci . 2018;157:93-104
44. Ji H, Xu X, Liu G, Liu H, Wang Q, Shen W, et al. Dopamine receptor
d4 promoter hypermethylation increases the risk of drug addiction.Exp Ther Med . 2018;15:2128-2133
45. Ji H, Wang Y, Jiang D, Liu G, Xu X, Dai D, et al. Elevated drd4
promoter methylation increases the risk of alzheimer’s disease in males.Mol Med Rep . 2016;14:2732-2738
46. Zhang R, Dang W, Zhang J, He R, Li G, Zhang L, et al. Methylation
quantitative locus rs3758653 in the drd4 gene is associated with
duration from first heroin exposure to addiction. Brain Res .
2022;1775:147746
47. Parkin GM, Udawela M, Gibbons A, Scarr E, Dean B.
Catechol-o-methyltransferase (comt) genotypes are associated with
varying soluble, but not membrane-bound comt protein in the human
prefrontal cortex. J Hum Genet . 2018;63:1251-1258
48. Dean B, Parkin GM, Gibbons AS. Associations between
catechol-o-methyltransferase (comt) genotypes at rs4818 and rs4680 and
gene expression in human dorsolateral prefrontal cortex. Exp Brain
Res . 2020;238:477-486
49. Dean B, Scarr E. Comt genotype is associated with differential
expression of muscarinic m1 receptors in human cortex. Am J Med
Genet B Neuropsychiatr Genet . 2016;171:784-789
50. Roussos P, Giakoumaki SG, Pavlakis S, Bitsios P. Planning,
decision-making and the comt rs4818 polymorphism in healthy males.Neuropsychologia . 2008;46:757-763
51. Madzarac Z, Tudor L, Sagud M, Nedic Erjavec G, Mihaljevic Peles A,
Pivac N. The associations between comt and mao-b genetic variants with
negative symptoms in patients with schizophrenia. Curr Issues Mol
Biol . 2021;43:618-636
52. Omair A, Mannion AF, Holden M, Fairbank J, Lie BA, Hagg O, et al.
Catechol-o-methyltransferase (comt) gene polymorphisms are associated
with baseline disability but not long-term treatment outcome in patients
with chronic low back pain. Eur Spine J . 2015;24:2425-2431
53. Fageera W, Chaumette B, Fortier ME, Grizenko N, Labbe A, Sengupta
SM, et al. Association between comt methylation and response to
treatment in children with adhd. J Psychiatr Res .
2021;135:86-93